Margarida Alves

Ingelheim Am Rhein, RP, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications

Real-world treatment patterns and determinants of therapy in systemic sclerosis: findings from the German Network for SSc cohort.

Real-world treatment patterns and determinants of therapy in systemic sclerosis: findings from the German Network for SSc cohort.

Journal: Arthritis research & therapy
Published: March 27, 2026

Circulating biomarkers in patients with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial.

Circulating biomarkers in patients with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial.

Journal: Annals of the rheumatic diseases
Published: January 29, 2026

Expert viewpoint on endpoints in systemic sclerosis: current and future outlook.

Expert viewpoint on endpoints in systemic sclerosis: current and future outlook.

Journal: RMD open
Published: January 28, 2026

Outcomes in Systemic Sclerosis-Associated Interstitial Lung Disease Based on Serological Profiles With a Focus on Anticentromere and Anti-RNA Polymerase III Antibodies.

Outcomes in Systemic Sclerosis-Associated Interstitial Lung Disease Based on Serological Profiles With a Focus on Anticentromere and Anti-RNA Polymerase III Antibodies.

Journal: The Journal of rheumatology
Published: March 25, 2025

Nailfold capillaroscopy in patients with systemic sclerosis-associated interstitial lung disease: a substudy of the SENSCIS trial.

Nailfold capillaroscopy in patients with systemic sclerosis-associated interstitial lung disease: a substudy of the SENSCIS trial.

Journal: RMD open
Published: March 20, 2025

Lung function and skin fibrosis changes as predictors of survival in SSc-associated interstitial lung disease: a EUSTAR study.

Lung function and skin fibrosis changes as predictors of survival in SSc-associated interstitial lung disease: a EUSTAR study.

Journal: Rheumatology (Oxford, England)
Published: December 10, 2024

Trajectories of forced vital capacity in patients with systemic sclerosis-associated interstitial lung disease.

Trajectories of forced vital capacity in patients with systemic sclerosis-associated interstitial lung disease.

Journal: Arthritis research & therapy
Published: October 07, 2024

Continued nintedanib in patients with systemic sclerosis-associated interstitial lung disease: 3-year data from SENSCIS-ON.

Continued nintedanib in patients with systemic sclerosis-associated interstitial lung disease: 3-year data from SENSCIS-ON.

Journal: RMD open
Published: October 04, 2024

Valproate in Psychiatric Practice: Risks to Fertility and Future Generations.

Valproate in Psychiatric Practice: Risks to Fertility and Future Generations.

Journal: Acta medica portuguesa
Published: September 08, 2024

Development of a multivariable prediction model for progression of systemic sclerosis-associated interstitial lung disease.

Development of a multivariable prediction model for progression of systemic sclerosis-associated interstitial lung disease.

Journal: RMD open
Published: February 19, 2024

Design of ANCHOR-RA: a multi-national cross-sectional study on screening for interstitial lung disease in patients with rheumatoid arthritis.

Design of ANCHOR-RA: a multi-national cross-sectional study on screening for interstitial lung disease in patients with rheumatoid arthritis.

Journal: BMC rheumatology
Published: September 07, 2023

Risk of Malnutrition in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease Treated With Nintedanib in the Randomized, Placebo-Controlled SENSCIS Trial.

Risk of Malnutrition in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease Treated With Nintedanib in the Randomized, Placebo-Controlled SENSCIS Trial.

Journal: Arthritis care & research
Published: February 23, 2023
Showing 1-12 of 32

Last Updated: 09/26/2026